NR565 Advanced Pharmacology Practice
Midterm Exam Study Guide 2026/2027
,NR565 Advanced Pharmacology Practice
Midterm Exam Study Guide 2026/2027
MULTIPLE CHOICE PRACTICE QUESTIONS
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS
Question 1
A nurse practitioner is explaining drug absorption to a patient. Which factor would MOST significantly
increase the absorption of an orally administered drug?
A) High molecular weight of the drug
B) Increased gastric pH in the presence of food
C) High lipid solubility of the drug
D) Protein binding greater than 90%
✅ Answer: C
Rationale: Highly lipid-soluble drugs cross cell membranes more readily, enhancing absorption through
the gastrointestinal tract. High molecular weight, altered gastric pH, and protein binding do not directly
increase absorption in the same manner.
Question 2
A patient is prescribed a drug with a narrow therapeutic index. Which pharmacokinetic parameter is
MOST critical for the NP to monitor?
A) Volume of distribution (Vd)
B) Half-life (t½)
C) Bioavailability
D) Peak and trough levels
✅ Answer: D
,Rationale: Drugs with a narrow therapeutic index (e.g., digoxin, lithium, warfarin) require close
monitoring of peak and trough levels to maintain efficacy while avoiding toxicity. Small changes in
dosing can have significant clinical consequences.
Question 3
Which of the following BEST describes the concept of "first-pass metabolism"?
A) Drug metabolism occurring in the kidneys before systemic circulation
B) Drug degradation in the gastrointestinal lumen before absorption
C) Hepatic metabolism of a drug after absorption but before reaching systemic circulation
D) Drug distribution to peripheral tissues after first administration
✅ Answer: C
Rationale: First-pass metabolism (hepatic first-pass effect) occurs when an orally absorbed drug is
metabolized in the liver before reaching systemic circulation, significantly reducing bioavailability.
Question 4
A 72-year-old patient with decreased renal function is prescribed a renally cleared medication. The NP
should anticipate:
A) Decreased half-life of the drug
B) Increased drug clearance
C) Accumulation of the drug and potential toxicity
D) Increased volume of distribution
✅ Answer: C
Rationale: Decreased renal function reduces drug clearance, leading to drug accumulation and potential
toxicity. Dose adjustments are essential in patients with renal impairment.
Question 5
, Which statement BEST describes the volume of distribution (Vd)?
A) The amount of drug excreted by the kidneys per unit time
B) A theoretical volume that relates the amount of drug in the body to its plasma concentration
C) The percentage of drug bound to plasma proteins
D) The rate at which a drug is eliminated from the body
✅ Answer: B
Rationale: Vd is a theoretical parameter that describes the relationship between the total amount of
drug in the body and the drug concentration measured in plasma. A large Vd indicates extensive tissue
distribution.
Question 6
A drug undergoes zero-order kinetics. This means:
A) A constant fraction of drug is eliminated per unit time
B) A constant amount of drug is eliminated per unit time regardless of concentration
C) The drug is eliminated exponentially
D) Doubling the dose doubles the plasma concentration proportionally
✅ Answer: B
Rationale: Zero-order kinetics involves elimination of a fixed amount of drug per unit time (not a fixed
fraction). Examples include ethanol and aspirin at toxic levels. This is clinically significant because small
dose increases can cause disproportionate plasma level increases.
Question 7
A patient is taking Drug A, which is a potent inhibitor of CYP3A4. They are also prescribed Drug B, which
is metabolized by CYP3A4. The NP should expect:
A) Decreased plasma levels of Drug B
Midterm Exam Study Guide 2026/2027
,NR565 Advanced Pharmacology Practice
Midterm Exam Study Guide 2026/2027
MULTIPLE CHOICE PRACTICE QUESTIONS
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS
Question 1
A nurse practitioner is explaining drug absorption to a patient. Which factor would MOST significantly
increase the absorption of an orally administered drug?
A) High molecular weight of the drug
B) Increased gastric pH in the presence of food
C) High lipid solubility of the drug
D) Protein binding greater than 90%
✅ Answer: C
Rationale: Highly lipid-soluble drugs cross cell membranes more readily, enhancing absorption through
the gastrointestinal tract. High molecular weight, altered gastric pH, and protein binding do not directly
increase absorption in the same manner.
Question 2
A patient is prescribed a drug with a narrow therapeutic index. Which pharmacokinetic parameter is
MOST critical for the NP to monitor?
A) Volume of distribution (Vd)
B) Half-life (t½)
C) Bioavailability
D) Peak and trough levels
✅ Answer: D
,Rationale: Drugs with a narrow therapeutic index (e.g., digoxin, lithium, warfarin) require close
monitoring of peak and trough levels to maintain efficacy while avoiding toxicity. Small changes in
dosing can have significant clinical consequences.
Question 3
Which of the following BEST describes the concept of "first-pass metabolism"?
A) Drug metabolism occurring in the kidneys before systemic circulation
B) Drug degradation in the gastrointestinal lumen before absorption
C) Hepatic metabolism of a drug after absorption but before reaching systemic circulation
D) Drug distribution to peripheral tissues after first administration
✅ Answer: C
Rationale: First-pass metabolism (hepatic first-pass effect) occurs when an orally absorbed drug is
metabolized in the liver before reaching systemic circulation, significantly reducing bioavailability.
Question 4
A 72-year-old patient with decreased renal function is prescribed a renally cleared medication. The NP
should anticipate:
A) Decreased half-life of the drug
B) Increased drug clearance
C) Accumulation of the drug and potential toxicity
D) Increased volume of distribution
✅ Answer: C
Rationale: Decreased renal function reduces drug clearance, leading to drug accumulation and potential
toxicity. Dose adjustments are essential in patients with renal impairment.
Question 5
, Which statement BEST describes the volume of distribution (Vd)?
A) The amount of drug excreted by the kidneys per unit time
B) A theoretical volume that relates the amount of drug in the body to its plasma concentration
C) The percentage of drug bound to plasma proteins
D) The rate at which a drug is eliminated from the body
✅ Answer: B
Rationale: Vd is a theoretical parameter that describes the relationship between the total amount of
drug in the body and the drug concentration measured in plasma. A large Vd indicates extensive tissue
distribution.
Question 6
A drug undergoes zero-order kinetics. This means:
A) A constant fraction of drug is eliminated per unit time
B) A constant amount of drug is eliminated per unit time regardless of concentration
C) The drug is eliminated exponentially
D) Doubling the dose doubles the plasma concentration proportionally
✅ Answer: B
Rationale: Zero-order kinetics involves elimination of a fixed amount of drug per unit time (not a fixed
fraction). Examples include ethanol and aspirin at toxic levels. This is clinically significant because small
dose increases can cause disproportionate plasma level increases.
Question 7
A patient is taking Drug A, which is a potent inhibitor of CYP3A4. They are also prescribed Drug B, which
is metabolized by CYP3A4. The NP should expect:
A) Decreased plasma levels of Drug B
